Last reviewed · How we verify
NCT04522362
Modeling Stress-precipitated Vaping Behavior
NA trial testing Control task and Trier Social Stress Task in Vaping in 51 participants. Completed in 30 June 2018.
30 June 2018
Quick facts
| Lead sponsor | Clemson University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 51 |
| Start date | 25 October 2017 |
| Primary completion | 30 June 2018 |
| Estimated completion | 30 June 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Control task and Trier Social Stress Task
Conditions studied
- Vaping — all drugs for Vaping →
Sponsor
Clemson University
Who can join
18 and older, any sex, with Vaping. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary aims of this pilot study were to (1) initially validate the applicability of a human laboratory model of relapse initially developed for smokers to e-cigarette users; (2) to use this human laboratory model of lapse behavior to examine the effects of acute psychological stress on vaping-lapse behavior among adults who are experienced, e-cigarette users.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Modeling the effect of stress on vaping behavior among young adults: A randomized cross-over pilot study.
Pericot-Valverde I, Heo M, Litwin AH, Niu J, et al · · 2021 · cited 5× · PMID 34091155 · DOI 10.1016/j.drugalcdep.2021.108798 -
Effects of short-term nicotine deprivation on delay discounting among young, experienced, exclusive ENDS users: An initial study.
Pericot-Valverde I, Yoon JH, Byrne KA, Heo M, et al · · 2023 · cited 2× · PMID 36355684 · DOI 10.1037/pha0000612
Verify or expand the search:
- PubMed search for NCT04522362
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Vaping
Currently open trials in the same condition.
- NCT07040566 — A Trial of Varenicline for E-cigarette Cessation · Phase 2 · recruiting
- NCT07116837 — Perceived Effectiveness of Vaping Prevention Ads Among Adolescents and Young Adults · NA · recruiting
- NCT06819969 — The Canadian Lung Outcomes in Users of Vaping Devices Study · recruiting
- NCT05999383 — Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration · Phase 2 · recruiting
- NCT06765291 — Behavioral Intervention for Youth to Promote Vaping Cessation · NA · recruiting
Other Clemson University trials
Trials by the same sponsor.
- NCT07140952 — Fueling Strong Hearts for a Strong South Carolina · NA · recruiting
- NCT06479681 — A Peer Recovery Coaching Intervention for Hospitalized Alcohol Use Disorder Patients · NA · recruiting
- NCT06088329 — Mindful Walking for Adults With Chronic Pain · NA · unknown
- NCT05347719 — Virtual Mindfulness Training for Adults With History of Depression · NA · completed
- NCT04651582 — The Everyday Function Intervention Trial · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04522362 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Clemson University
- Last refreshed: 21 August 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04522362.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing